SUMMARY The sensitivity of methods to detect antibodies to intrinsic factor was assessed. Five sera of known antibody content were tested in 31 laboratories and 30 sera from patients with pernicious anaemia were tested in one laboratory. Five non-commercial methods and two kits for type I antibodies and one non-commercial method for types I and II antibodies are in current use. Differences in sensitivity of the non-commercial methods for type I antibodies related more to the antigen:antibody ratio in the test system than to the method itself. A radioimmune assay for types I and II antibodies showed the best sensitivity but that of an enzyme linked immunosorbent assay (ELISA) method was poor Type I antibodies (IFA) to intrinsic factor, which block the binding of cobalamin to intrinsic factor, have been recorded in the 31% to 76% ofpatients with pernicious anaemia.' This large variation may be due to case selection or to differences in technique used, or both. Because the detection ofIFA may avoid the need for further investigation in the diagnosis of pernicious anaemia we compared the sensitivity of some of the methods in current use, including two which detect type II antibodies (inhibitors of the attachment of intrinsic factor to the ileal mucosa) at the same time. Tests for type II antibodies alone are not often used because the antibodies are thought to be less common than type I antibodies, though this may not be so.2
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Material and methods
Sera were collected from patients with pernicious anaemia and from a healthy control. These were coded and sent to laboratories which undertake IFA testing and which had agreed to test samples for us. Two sera from patients with pernicious anaemia containing, respectively, 6 and 2 units IFA/ml were issued first and on a second occasion, patients' serum containing 10 units IFA/ml together with this serum diluted by a factor of 8 and 10 in the normal serum, and the normal serum were sent.
The methods used by participants were those of Ardeman and Chanarin,3 of Gottlieb et al,4 and of Ghazi,5 using gastric juice, commercial intrinsic factor, Accepted for publication 23 August 1988 or the reagents from a commercial B12 kit (Becton Dickinson; BD); and the IFA kit of Corning and the IFbab kit of Diagnostic Products Corporation UK(DPC). Two other methods used were the radioimmune assay with '25I-labelled intrinsic factor of Conn6 and the Melisa kit, a micro/ELISA technique, of Walker Laboratories Ltd. Both these are said to detect types I and II antibodies simultaneously.
Thirty sera from other patients with pernicious anaemia and 20 sera from surgical patients were collected for a comparative study in our laboratory of the methods of the IFbab and Melisa kits. For the Ardeman and Chanarin method 1 25 ng intrinsic factor and 300 pl serum were used and for Ghazi method 3 ng intrinsic factor and 200 pl serum per tube were used.
Results
Thirty one and 29 laboratories returned results for the two issues, respectively. The results with the five patient sera are shown in table 1, according to method used. That of Conn-used by two participants-gave the highest detection rate. The four other non-commercial methods gave a similar incidence of positive results. All laboratories recorded the normal serum as negative.
In table 3 show that with 4-2 units intrinsic factor/ml serum the Ardeman and Chanari method gave the same results as the Ghazi method with 10 units intrinsic factor/serum (the proportion expected with the average gastric juice). Thus there is no advantage in using the Ghazi method with its additional control tubes.
We therefore recommend the Ardeman and Chanarin method for routine use with 1 25 ng intrinsic factor and 300 pI serum per tube. These proportions detected the weakest antibodies in the inter-laboratory issues. With these volumes an incubation time for the antigen:antibody reaction extended to 30 minutes is preferable. We also suggest a change in the calculation of the binding inhibition with the non-commercial type I methods. The formulae customarily used require the difference between negative control (= 100% intrinsic factor activity) and the test serum counts to be calculated. At low concentrations of inhibition this difference is small and the total error large. The ratio of control to test counts reduces this error and improves the ability to detect low concentrations of IFA. The greater incidence of positive results with the Conn method are probably because it detects type II antibodies also. If this is the case it implies that the Conn method is less sensitive to type I antibodies as it missed three. We did, however, have technical problems with the method. The '25I label readily came off the intrinsic factor on storage, necessitating the addition of more intrinsic factor to the system (and removal of free isotope by charcoal), with subsequent reduction in sensitivity. If type II antibodies are as common as type I antibodies a sensitive method which detects both should be at an advantage: The Conn method was a case in point; the Melisa was not.
